Merck, Cipla Avoiding Compulsory License?
  • Prabha Hedge
  • Feb 26 2014

February 26: In a bid to skirt compulsory licenses issued by the Indian government, foreign drug makers are tying up with local partners to sign exclusive product licensing deals. The most recent instance seems of the agreement between Merck and Cipla to market the AIDS drug Raltegravir in India.